Skip to main content
NCBI home page
Molecular Medicine logoLink to Molecular Medicine
. 1999 Jan;5(1):55–61.

Presence of P210bcrabl is associated with decreased expression of a beta chemokine C10 gene in a P210bcrabl-positive myeloid leukemia cell line.

C M Lane 1, X Y Guo 1, L H Macaluso 1, K C Yung 1, A B Deisseroth 1
PMCID: PMC2230372  PMID: 10072448

Abstract

BACKGROUND: Chronic myelogenous leukemia (CML) is thought to start with the acquisition of the t(9;22) chromosomal translocation that codes for the P210bcrabl tyrosine-specific protein kinase. The CML cells exhibit anchorage-independent cell growth and genetic instability. After the initial phase, the cells acquire the phenotype of growth factor-independent growth. After the chronic phase, the disease evolves into the accelerated and blastic phases through the process of sequential random mutation. MATERIALS AND METHODS: To identify some of the genetic changes that contribute to the phenotype of blastic and accelerated phase cells, we used differential display PCR to compare levels of cDNA reverse transcripts of mRNA in 32Dc13 cells and 32Dc13 cells that were stably transfected with a bcrabl cDNA plasmid in a constitutively expressed transcription unit. These cells were designated 32Dc13P210bcrabl. For these studies, we used the 32D myeloid leukemia cell line, which depends on IL-3 for growth. RESULTS: Following introduction of the bcr-abl cDNA through transfection, the cell line became growth factor independent, mimicking the change in phenotype that occurs during the later phases of CML. These differential display screening assays detected altered levels of transcripts for 28 genes. Of interest to the biology of growth factor-independent growth in the bcrabl-positive 32D cells was the fact that the C10 beta chemokine gene was expressed at higher levels in the 32Dc13 cells than in the 32Dc13P210bcrabl cells. CONCLUSIONS: These studies show that a C10 beta chemokine gene was expressed at different levels with or without P210bcrabl.

Full text

PDF
55

Images in this article

57Fig. 1
on p.57
58Fig. 2
on p.58
59Fig. 3
on p.59
59Fig. 4
on p.59

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhatia R., McGlave P. B., Verfaillie C. M. Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha. J Clin Invest. 1995 Aug;96(2):931–939. doi: 10.1172/JCI118141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chasty R. C., Lucas G. S., Owen-Lynch P. J., Pierce A., Whetton A. D. Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia. Blood. 1995 Dec 1;86(11):4270–4277. [PubMed] [Google Scholar]
  3. Cohen L., Mohr R., Chen Y. Y., Huang M., Kato R., Dorin D., Tamanoi F., Goga A., Afar D., Rosenberg N. Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12448–12452. doi: 10.1073/pnas.91.26.12448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cortes J. E., O'Brien S. Chronic myelogenous leukemia. Curr Opin Oncol. 1994 Jan;6(1):23–31. doi: 10.1097/00001622-199401000-00004. [DOI] [PubMed] [Google Scholar]
  5. Eaves C. J., Cashman J. D., Wolpe S. D., Eaves A. C. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12015–12019. doi: 10.1073/pnas.90.24.12015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hirose K., Hakozaki M., Nyunoya Y., Kobayashi Y., Matsushita K., Takenouchi T., Mikata A., Mukaida N., Matsushima K. Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br J Cancer. 1995 Sep;72(3):708–714. doi: 10.1038/bjc.1995.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Johnson E., Henzel W., Deisseroth A. An isoform of protein disulfide isomerase isolated from chronic myelogenous leukemia cells alters complex formation between nuclear proteins and regulatory regions of interferon-inducible genes. J Biol Chem. 1992 Jul 15;267(20):14412–14417. [PubMed] [Google Scholar]
  8. Jung M., Kondratyev A. D., Dritschilo A. Elongation factor 1 delta is enhanced following exposure to ionizing radiation. Cancer Res. 1994 May 15;54(10):2541–2543. [PubMed] [Google Scholar]
  9. Konopka J. B., Watanabe S. M., Witte O. N. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell. 1984 Jul;37(3):1035–1042. doi: 10.1016/0092-8674(84)90438-0. [DOI] [PubMed] [Google Scholar]
  10. Kubota H., Hynes G., Willison K. The eighth Cct gene, Cctq, encoding the theta subunit of the cytosolic chaperonin containing TCP-1. Gene. 1995 Mar 10;154(2):231–236. doi: 10.1016/0378-1119(94)00880-2. [DOI] [PubMed] [Google Scholar]
  11. Laneuville P., Sun G., Timm M., Vekemans M. Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl. Blood. 1992 Oct 1;80(7):1788–1797. [PubMed] [Google Scholar]
  12. Liang P., Averboukh L., Zhu W., Pardee A. B. Ras activation of genes: Mob-1 as a model. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12515–12519. doi: 10.1073/pnas.91.26.12515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liang P., Pardee A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992 Aug 14;257(5072):967–971. doi: 10.1126/science.1354393. [DOI] [PubMed] [Google Scholar]
  14. NOWELL P. C., HUNGERFORD D. A. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960 Jul;25:85–109. [PubMed] [Google Scholar]
  15. Nirsimloo N., Gordon M. Y. Progenitor cells in the blood and marrow of patients with chronic phase chronic myeloid leukaemia respond differently to macrophage inflammatory protein-1 alpha. Leuk Res. 1995 May;19(5):319–323. doi: 10.1016/0145-2126(94)00143-x. [DOI] [PubMed] [Google Scholar]
  16. Orlofsky A., Berger M. S., Prystowsky M. B. Novel expression pattern of a new member of the MIP-1 family of cytokine-like genes. Cell Regul. 1991 May;2(5):403–412. doi: 10.1091/mbc.2.5.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Orlofsky A., Lin E. Y., Prystowsky M. B. Selective induction of the beta chemokine C10 by IL-4 in mouse macrophages. J Immunol. 1994 May 15;152(10):5084–5091. [PubMed] [Google Scholar]
  18. Rowley J. D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973 Jun 1;243(5405):290–293. doi: 10.1038/243290a0. [DOI] [PubMed] [Google Scholar]
  19. Sager R., Anisowicz A., Neveu M., Liang P., Sotiropoulou G. Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene. FASEB J. 1993 Jul;7(10):964–970. doi: 10.1096/fasebj.7.10.8344495. [DOI] [PubMed] [Google Scholar]
  20. Schall T. J., Bacon K. B. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol. 1994 Dec;6(6):865–873. doi: 10.1016/0952-7915(94)90006-x. [DOI] [PubMed] [Google Scholar]
  21. Shinoura N., Shamraj O. I., Hugenholz H., Zhu J. G., McBlack P., Warnick R., Tew J. J., Wani M. A., Menon A. G. Identification and partial sequence of a cDNA that is differentially expressed in human brain tumors. Cancer Lett. 1995 Mar 2;89(2):215–221. doi: 10.1016/0304-3835(95)03690-x. [DOI] [PubMed] [Google Scholar]
  22. Sternlicht H., Farr G. W., Sternlicht M. L., Driscoll J. K., Willison K., Yaffe M. B. The t-complex polypeptide 1 complex is a chaperonin for tubulin and actin in vivo. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9422–9426. doi: 10.1073/pnas.90.20.9422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Su Y., Raj N. B., Au W. C., Pitha P. M. Primary sequence of the mouse ribosomal protein L37a. Nucleic Acids Res. 1993 Sep 11;21(18):4400–4400. doi: 10.1093/nar/21.18.4400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wetzler M., Talpaz M., Estrov Z., Kurzrock R. CML: mechanisms of disease initiation and progression. Leuk Lymphoma. 1993;11 (Suppl 1):47–50. doi: 10.3109/10428199309047863. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES